MOCLOBEMIDE IN SOCIAL PHOBIA - A PILOT OPEN STUDY

被引:19
|
作者
BISSERBE, JC [1 ]
LEPINE, JP [1 ]
LEGOUBEY, P [1 ]
RIGAUD, P [1 ]
ALBERT, E [1 ]
CHNEWEISS, L [1 ]
RIOUX, P [1 ]
机构
[1] HOP BICHAT,PRATICIEN HOSP,PARIS,FRANCE
关键词
MONOAMINE OXIDASE INHIBITOR; MOCLOBEMIDE; SOCIAL PHOBIA;
D O I
10.1097/00002826-199417001-00010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In an open-label pilot study, 35 outpatients with social phobia (DSM-III-R) received moclobemide for 12 weeks. The dosing range was 300-600 mg/ day. Eighteen patients completed the study and 28 received at least 4 weeks of treatment. There was a consistent improvement in the efficacy parameters. Moclobemide was effective in both major components of social phobia (fear and avoidance). Moclobemide seems as effective as conventional irreversible monoamine oxidase inhibitors. Tolerability was good apart from one occurrence of grand mal seizure.
引用
收藏
页码:S88 / S94
页数:7
相关论文
共 50 条
  • [1] Moclobemide in social phobia
    Duffett, R
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1998, 172 : 451 - 452
  • [2] Fluoxetine in social phobia: An open pilot study
    Koponen, HJ
    Lepola, U
    Leinonen, E
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 1998, 52 (02) : 141 - 146
  • [3] Moclobemide in the treatment of social phobia
    Nutt, D
    Montgomery, SA
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 : 77 - 82
  • [4] Moclobemide in social phobia: Assessment of efficacy
    Burrows, GD
    [J]. FOCUS ON DEPRESSION AND ANXIETY, 1996, 7 (04): : 81 - 81
  • [5] PHARMACOTHERAPY OF SOCIAL PHOBIA - A CONTROLLED-STUDY WITH MOCLOBEMIDE AND PHENELZINE
    VERSIANI, M
    NARDI, AE
    MUNDIM, FD
    ALVES, AB
    LIEBOWITZ, MR
    AMREIN, R
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1992, 161 : 353 - 360
  • [6] Cognitive therapy versus moclobemide in social phobia: A controlled study
    Oosterbaan, DB
    van Balkom, AJLM
    Spinhoven, P
    van Oppen, P
    van Dyck, R
    [J]. CLINICAL PSYCHOLOGY & PSYCHOTHERAPY, 2001, 8 (04) : 263 - 273
  • [7] A pilot study of PET in social phobia
    Van Ameringen, M
    Mancini, C
    Oakman, JM
    Kamath, M
    Nahmias, C
    Szechtman, H
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 : 31S - 31S
  • [8] The long-term treatment of social phobia with moclobemide
    Versiani, M
    Nardi, AE
    Mundim, FD
    Pinto, S
    Saboya, E
    Kovacs, R
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 : 83 - 88
  • [9] Dimensional versus categorical response to moclobemide in social phobia
    Blanco, C
    Liebowitz, MR
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (04) : 344 - 345
  • [10] Cardiovascular reflexes during treatment of social phobia with moclobemide
    Coupland, NJ
    Bell, C
    Potokar, JP
    Bailey, JE
    Nutt, DJ
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2001, 5 (01) : 27 - 31